FDA Inspection 1231140 — AptaPharma Inc.
The FDA completed an inspection of AptaPharma Inc. on Oct 24, 2024 in Pennsauken, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pennsauken, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)